%0 Journal Article
%T Biomarkers and Biochemical Indicators to Evaluate Bone Metabolism in Preterm Neonates.
%A D'Amato G
%A Brescia V
%A Fontana A
%A Natale MP
%A Lovero R
%A Varraso L
%A Di Serio F
%A Simonetti S
%A Muggeo P
%A Faienza MF
%J Biomedicines
%V 12
%N 6
%D 2024 Jun 7
%M 38927478
%F 4.757
%R 10.3390/biomedicines12061271
%X The purpose of the present study was to evaluate the concentrations of some bone turnover markers in preterm neonates with uncomplicated clinical course in the first month of life. Samples from 13 preterm neonates were collected at three different times: at birth (T0) from umbilical cord blood (UCB); and at 15 (T1) and 30 (T2) days of life from peripheral blood (PB). The concentrations of calcium (Ca), phosphate (P), total alkaline phosphatase (ALP), Collagen Type 1 Amino-terminal Propeptide (PINP), osteocalcin (OC), Collagen Type 1 Carboxyl-Terminal Telopeptide (CTX) and Leptin were assessed. A statistically significant difference for ALP concentration at birth versus T1 and T2 was found. An evident increase in the median concentrations of CTX, OC and PINP from T0 to T2 were observed. A significant difference was also found for Leptin concentration at T0 compared to T1. In preterm infants, in the absence of acute or chronic medical conditions and without risk factors for metabolic bone disease (MBD) of prematurity, there is a significant increase in bone turnover markers during the first month of life. The knowledge of the variations in these markers in the first weeks of life, integrated by the variations in the biochemical indicators of bone metabolism, could help in recognizing any conditions at risk of developing bone diseases.